Otsuka Holdings Co., Ltd. (FRA:OS1)

Market Cap	24.04B
Revenue (ttm)	14.17B
Net Income (ttm)	2.41B
Shares Out	n/a
EPS (ttm)	4.50
PE Ratio	9.96
Forward PE	n/a
Dividend	0.78 (1.72%)
Ex-Dividend Date	Jun 27, 2025

Volume	n/a
Average Volume	98
Open	45.80
Previous Close	46.40
Day's Range	45.80 - 46.60
52-Week Range	37.60 - 59.00
Beta	n/a
RSI	74.37
Earnings Date	Jul 31, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 35,338
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OS1

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.

Financial numbers in JPY